Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
JMIR Human Factors|May 14, 2016
The Usability of Diabetes MAP: A Web-delivered Intervention for Improving Medication AdherenceLyndsay A Nelson, Magaela C Bethune, Andrea E Lagotte, et al.
Virchows Archiv : an International Journal of Pathology|February 2, 2021
Assessment of HER2 using the 2018 ASCO/CAP guideline update for invasive breast cancer: a critical look at cases classified as HER2 2+ by immunohistochemistryValerie J Taylor, Penny J Barnes, Sean C Godwin, et al.
Clinical Breast Cancer|May 13, 2019
Isolated Tumor Cells in Sentinel Lymph Nodes of Primary Invasive Breast Carcinoma: A Cohort AnalysisGillian C Bethune, Manolhas A Karkada, Ryan DeCoste, et al.
Pharmaceutical Research|July 9, 1999
Lipid association increases the potency against primary medulloblastoma cells and systemic exposure of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in ratsC Bethune, A Blum, J R Geyer, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
Development of a high-performance liquid chromatographic assay for G418 sulfate (Geneticin)C Bethune, T Bui, M L Liu, et al.
Breast (Edinburgh, Scotland)|March 23, 2024
Is Oncotype DX testing informative for breast cancers with low ER expression? A retrospective review from a biomarker testing referral centerJohn Loggie, Penelope J Barnes, Michael D Carter, et al.
Journal of Attention Disorders|August 4, 2022
The Impact of Internalizing Symptoms on Impairment for Children With ADHD: A Strength-Based PerspectiveSarah C Bethune, Maria A Rogers, David Smith, et al.
Histopathology|December 30, 2016
Well-differentiated invasive breast cancers with equivocal HER2 immunohistochemistry: what is the yield of routine reflex in-situ hybridization testing?Gillian C Bethune, Alexandra S L Pettit, Daniel Veldhuijzen van Zanten, et al.
Annals of Diagnostic Pathology|April 29, 2022
HER2 testing in metastatic breast cancer - Is reflex ISH testing necessary on HER2 IHC-equivocal (2+) cases?Christopher R Liwski, Mathieu C Castonguay, Penny J Barnes, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 17, 2022
Using Deep Learning to Predict Final HER2 Status in Invasive Breast Cancers That are Equivocal (2+) by ImmunohistochemistrySean A Rasmussen, Valerie J Taylor, Alexi P Surette, et al.
Pageof 3